用联合抗高血压药物治疗的高血压患者患高卡血症的风险 - - 基于登记的回顾性研究
Fatma Luai Mahdi Al-Janabi1, Fatme Moussa2, Sarah Taleb1
1Faculty of Medicine, Aalborg University, Aalborg, Denmark.
概括
结合β抑制剂 (BB),氨酸-血管新生系统抑制剂 (RASi) 和矿物质皮质类受体对抗剂 (MRA),在90天内显著增加高血症的风险. 在开始这种抗高血压疗法时,仔细监测失血症至关重要.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 超血是抗高血压药物治疗的严重副作用之一.
- 不同的抗高血压药物组合中高血的比较风险尚未得到充分理解.
研究的目的:
- 调查与各种抗高血压药物治疗组合相关的高胆血症发展风险.
- 为了确定与高血风险增加相关的特定抗高血压组合.
主要方法:
- 基于登记的丹麦研究,使用发病率密度匹配.
- 根据eGFR,年龄,性别和时间,匹配了793名高胆固醇患者和3598名正常胆固醇患者.
- 多变量条件逻辑回归用于估计八组组合治疗组的90天内高卡莱米亚几率.
主要成果:
- 与RASi + thiazides相比,β阻塞剂 (BB) + 雷宁-血管新生素系统抑制剂 (RASi) + 矿物质皮质类受体对抗剂 (MRA) 的组合显示,高血的几率显著增加 (OR 1.95;95% CI,1.39-2.72).
- 诸如CCB + thiazides和CCB + RASi + thiazides之类的组合并没有与高血症显著相关.
- 启动BB + RASi + MRA治疗与90天内高血症的风险更高有关.
结论:
- 结合BB + RASi + MRA与显著增加高血症的风险有关.
- 在处方组合抗高血压药物治疗时,识别和监测患有失血症高风险的患者至关重要.
- 这一发现凸显了需要仔细选择和监测患者,以防止与高胆血症相关的不良结果.
相关概念视频
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
464
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
464
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
01:22Heart Failure Drugs: Diuretics
346
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
346
01:16Antihypertensive Drugs: Action of Diuretics
624
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
624
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
499
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
499